申请人:INSERM
公开号:US20030027743A1
公开(公告)日:2003-02-06
A compound of the formula
1
wherein the substituents are defined as in the specification and salts or hydrates thereof is disclosed as well as a method of treating disorders associated with the inactivation or excessive degradation of cholecystokinin.
本发明揭示了式1的化合物,其中置换基如规范中所定义,以及其盐或水合物,以及一种治疗与胆囊收缩素失活或过度降解相关的疾病的方法。